Dave King joins ACLA as Special Advisor
WASHINGTON, D.C. — The American Clinical Laboratory Association (ACLA) today announced Dave King, former CEO of Laboratory Corporation of America Holdings (LabCorp), will join ACLA as a special advisor.
Building on his twenty years of service to the industry, including more than a decade serving on the ACLA board, King will support the association’s strategic and tactical responses to the COVID-19 pandemic. In this role, he will also work closely with ACLA members to share information about emerging supply needs and help support the sharing of best practices. He will also assist the association in communications with the White House Coronavirus Task Force and other governmental agencies.
“A fierce advocate for our industry, Dave’s depth of knowledge has been a great asset to our membership for over a decade,” said Julie Khani, President of ACLA. “As our nation confronts this unprecedented challenge, we are grateful to have his steady voice of reason and considerable expertise on our team.”
King stepped down from his role as CEO of LabCorp in October 2019, and until May 13, 2020 will continue to serve as Executive Chairman of the Board.
# # #
ACLA is a not-for-profit association representing the nation’s leading clinical and anatomic pathology laboratories, including national, regional, specialty, hospital, ESRD and nursing home laboratories. The clinical laboratory industry employs nearly 295,000 people directly, and generates over 117,000 additional jobs in supplier industries. Clinical laboratories are at the forefront of personalized medicine, driving diagnostic innovation and contributing more than $106 billion to the nation’s economy.